文献速递冠心病

急性心肌梗死合并多支病变:FFR 指导与造影指导策略的随机试验

Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial.
PubMed 文献 · Eur Heart J · 2023-01-01

该随机试验纳入急性心肌梗死合并多支冠状动脉病变且梗死相关动脉 PCI 成功的患者,比较 FFR 指导(FFR ≤0.80)与造影指导(直径狭窄 >50%)处理非梗死相关动脉病变。共 562 例随机,中位随访 3.5 年,FFR 组主要终点(死亡、MI 或重复血运重建)发生率 7.4%,造影组 19.7%(HR 0.43,95%CI 0.25-0.75,P=0.003)。

要点

  • FFR 指导组非梗死相关动脉 PCI 比例 64.1%,低于造影指导组的 97.1%。
  • FFR 指导组主要终点风险显著低于造影指导组(HR 0.43,95%CI 0.25-0.75)。
  • FFR 指导组支架使用数更少(2.2±1.1 vs 2.5±0.9,P<0.001)。

核心结论

  • 在急性 MI 合并多支病变患者中,对非梗死相关动脉病变采用 FFR 指导的选择性 PCI 策略,在死亡、MI 或重复血运重建风险方面优于基于造影直径狭窄的常规 PCI 策略。

研究设计与样本

  • 随机试验,纳入急性 MI 合并多支冠状动脉病变且梗死相关动脉 PCI 成功的患者,随机分为 FFR 指导 PCI(FFR ≤0.80)或造影指导 PCI(直径狭窄 >50%)处理非梗死相关动脉病变,共 562 例。

主要发现

  • 中位随访 3.5 年(四分位距 2.7-4.1 年),主要终点在 FFR 组 284 例中发生 18 例(7.4%),造影组 278 例中发生 40 例(19.7%)(HR 0.43,95%CI 0.25-0.75,P=0.003)。
  • 死亡在 FFR 组发生 5 例(2.1%),造影组 16 例(8.5%);MI 分别为 7 例(2.5%)和 21 例(8.9%);非计划血运重建分别为 10 例(4.3%)和 16 例(9.0%)。
  • FFR 指导组非梗死相关动脉 PCI 比例为 64.1%,造影指导组为 97.1%;FFR 组支架使用数显著更少(2.2±1.1 vs 2.5±0.9,P<0.001)。
  • 60.0% 患者接受非梗死相关动脉病变的即时 PCI,40.0% 在同次住院期间接受分期手术。

关键数值与推荐

  • FFR 指导组对非梗死相关动脉病变在 FFR ≤0.80 时行 PCI。
  • 造影指导组对非梗死相关动脉病变在直径狭窄 >50% 时行 PCI。
  • 主要终点为死亡、MI 或重复血运重建的复合终点。

临床怎么用

  • 对急性 MI 合并多支病变且梗死相关动脉已成功 PCI 的患者,可考虑采用 FFR 指导的非梗死相关动脉选择性 PCI 策略,以减少不必要的支架植入并改善预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: In patients with acute myocardial infarction (MI) and multivessel coronary artery disease, percutaneous coronary intervention (PCI) of non-infarct-related artery reduces death or MI. However, whether selective PCI guided by fractional flow reserve (FFR) is superior to routine PCI guided by angiography alone is unclear. The current trial sought to compare FFR-guided PCI with angiography-guided PCI for non-infarct-related artery lesions among patients with acute MI and multivessel disease. METHODS AND RESULTS: Patients with acute MI and multivessel coronary artery disease who had undergone successful PCI of the infarct-related artery were randomly assigned to either FFR-guided PCI (FFR ≤0.80) or angiography-guided PCI (diameter stenosis of >50%) for non-infarct-related artery lesions. The primary end point was a composite of time to death, MI, or repeat revascularization. A total of 562 patients underwent randomization. Among them, 60.0% underwent immediate PCI for non-infarct-related artery lesions and 40.0% were treated by a staged procedure during the same hospitalization. PCI was performed for non-infarct-related artery in 64.1% in the FFR-guided PCI group and 97.1% in the angiography-guided PCI group, and resulted in significantly fewer stent used in the FFR-guided PCI group (2.2 ± 1.1 vs. 2.5 ± 0.9, P < 0.001). At a median follow-up of 3.5 years (interquartile range: 2.7-4.1 years), the primary end point occurred in 18 patients of 284 patients in the FFR-guided PCI group and in 40 of 278 patients in the angiography-guided PCI group (7.4% vs. 19.7%; hazard ratio, 0.43; 95% confidence interval, 0.25-0.75; P = 0.003). The death occurred in five patients (2.1%) in the FFR-guided PCI group and in 16 patients (8.5%) in the angiography-guided PCI group; MI in seven (2.5%) and 21 (8.9%), respectively; and unplanned revascularization in 10 (4.3%) and 16 (9.0%), respectively. CONCLUSION: In patients with acute MI and multivessel coronary artery disease, a strategy of selective PCI using FFR-guided decision-making was superior to a strategy of routine PCI based on angiographic diameter stenosis for treatment of non-infarct-related artery lesions regarding the risk of death, MI, or repeat revascularization.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Lee, Kim, Park, et al. Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial. Eur Heart J. 2023. PMID: 36540034. doi:10.1093/eurheartj/ehac763

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。